Home › Mild Cognitive Impairment › Michigan › Ann Arbor
Mild Cognitive Impairment clinical trials in Ann Arbor, MI
5 studies for Mild Cognitive Impairment are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Recruiting
- Michigan Medicine, Ann Arbor
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecruitingPhase 4Healthy volunteers welcome
- VA Ann Arbor Healthcare System, Ann Arbor
- University of Michigan, Ann Arbor
Improve New Learning and Memory in Individuals With Mild Cognitive Impairment
Recruiting
- University of Michigan, Ann Arbor
Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
RecruitingPhase 2
- University of Michigan, Ann Arbor
Multimodal Investigation of Neural Plasticity
RecruitingHealthy volunteers welcome
- University of Michigan, Ann Arbor
About Mild Cognitive Impairment
In mild cognitive impairment (MCI), you have more memory and thinking problems than others your age, but they don't interfere with your everyday life.
More about Mild Cognitive Impairment on MedlinePlus
Mild Cognitive Impairment trials in other cities
- New York City, NY23 studies
- Boston, MA21 studies
- Chicago, IL17 studies
- Baltimore, MD16 studies
- Los Angeles, CA12 studies
- Philadelphia, PA11 studies
- Miami, FL11 studies
- Birmingham, AL11 studies
- Houston, TX10 studies
- San Francisco, CA10 studies
- Durham, NC9 studies
- St. Louis, MO9 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Breast Cancer26 studies
- Cancer (all types)26 studies
- Non-Small Cell Lung Cancer25 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Lung Cancer22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.